The Essential Biotech Investment Guide: How to Invest in the Healthcare Biotechnology & Life Sciences SectorWorld Scientific, 2002 - 261 páginas This invaluable book tells the reader how to invest in the healthcare biotechnology and life sciences sector, one of the fast-growing sectors of the US economy. Aimed at biotech investors as well as bioentrepreneurs and venture capitalists, it has been written from the perspectives of risk management and asset management/allocation. It strives to teach readers how to fish, rather than giving them fish. The author has over ten years of Wall Street experience in biotech research, investment banking and asset management. He holds an MBA in Finance and a PhD in Biochemistry. |
Contenido
CHAPTER 1 | 25 |
Past Reasons for Not Investing | 35 |
Bonds | 44 |
CHAPTER 2 | 51 |
CHAPTER 4 | 79 |
CHAPTER 5 | 91 |
Biotech Company Analysis | 97 |
80 | 107 |
CHAPTER 8 | 155 |
CHAPTER 9 | 163 |
CHAPTER 10 | 175 |
CHAPTER 11 | 181 |
CHAPTER 12 | 189 |
CHAPTER 13 | 195 |
CHAPTER 14 | 201 |
EPILOGUE | 215 |
Discounted Cash Flow DCF Analysis | 116 |
Investing in Undervalued Healthcare BiotechProactive | 123 |
CHAPTER 6 | 131 |
The Cost of Delaying | 139 |
APPENDIX B | 229 |
APPENDIX C | 253 |
Otras ediciones - Ver todas
Essential Biotech Investment Guide, The: How To Invest In The Healthcare ... Tang Mark Chilung Vista previa limitada - 2002 |
The Essential Biotech Investment Guide: How to Invest in the Healthcare ... Chilung Mark Tang,Mark Chilung Tang Sin vista previa disponible - 2002 |
Términos y frases comunes
Amgen analysis annual asset allocation average base pairs beneficiaries benefit biotech companies biotech industry biotech options biotech stock Biotechnology bonds book value Cap Growth capital gains cell chromosome clinical trials company's comparable firms corporate cycle disease diversified dividends earnings EBITDA economic ETFs expected growth federal Figure free cash flow gene Genetech genetic Genzyme growth rate Healthcare hedge fund human genome income Index Funds indicators inflation interest rates intrinsic value investors iShares long-term market value million molecule mutual funds Nasdaq North America nucleotides P/E ratios patent PEG Ratios performance Pharma Pharmaceuticals Phase portfolio potential Price/Book Value price/earnings Price/Sales price/sales ratios private equity private equity investing profitable protein purchase put option rate of return risk Sciences sector securities sell sequence stage stock price strategy Table trading trust undervalued usually valuation value investing Yes Yes